Loading clinical trials...
Loading clinical trials...
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Conditions
Interventions
Transcatheter Mitral Valve Re-placement (TMVR) with the CardiAQ-Edwards™ Transcatheter Mitral Valve
Locations
15
Canada
St. Paul's Hospital, University of British Columbia
Vancouver, British Columbia, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Centre Toronto General Hospital
Toronto, Ontario, Canada
Centre de recherche Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ)
Québec, Canada
Rigshospitalet
Copenhagen, Denmark
Centre Hospitalier Régional Universitaire de Lille
Lille, France
Start Date
November 1, 2016
Primary Completion Date
October 1, 2019
Completion Date
October 1, 2024
Last Updated
January 9, 2018
NCT04919980
NCT06465745
NCT04577248
NCT05090540
NCT04177394
NCT05010746
Lead Sponsor
Edwards Lifesciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions